Orion Pharma

Orion Pharma Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being. Welcome to Orion Pharma page!

On this page, we share information related to Orion Pharma's activities and building well-being. We hope all visitors to the page will behave kindly and respectfully, and honor others' opinions. Please follow the common rules of the page. Inappropriate, offensive, or derogatory messages do not belong in the community spirit, and we reserve the right to remove such comments without warning. Additio

nally, posts that are unrelated to the topic at hand will be removed. Such messages may include comments made for advertising purposes. As a pharmaceutical company, our communication is guided by laws and regulations related to the pharmaceutical industry, as well as ethical guidelines for pharmaceutical marketing. We cannot provide individual treatment instructions or respond to product inquiries on our social media pages. Instead, we ask you to contact your doctor or pharmacy staff for these matters. We cannot give instructions on the use of prescription drugs or provide advice related to your medication. On this page, we also cannot market prescription products from Orion Pharma or other companies to consumers, so we must remove comments that mention the names of medicinal products. We hope for your understanding in this matter. We reserve the right to moderate discussions. Commenting on posts is possible, but starting new discussion threads is not. We reserve the right to remove comments without warning if:

- They relate to prescription drug products. Marketing prescription drugs to consumers is prohibited by Finnish law. Therefore, we cannot publish the names of products on our pages.
- Comments contain individual treatment instructions or recommendations for the use of medicines, or they relate to the treatment of diseases or the use of medicinal products. We cannot provide individual treatment instructions or recommendations on our page. If you need advice on treating a disease or using medicinal products, please contact your doctor or pharmacy.
- We reserve the right to remove comments at our discretion in cases other than those mentioned above. Adverse Drug Reactions

If you want to report a possible adverse reaction to an Orion Pharma medicinal product, you can make an adverse reaction report to the email address: [email protected], or by calling the number: 010 426 2928. The format of the report is free. For drug safety reasons, Orion Pharma may contact you for additional information. Disclaimer

Orion Corporation is not responsible for the comments made by writers on our wall or for any direct or indirect damages caused by conclusions or actions based on them. There may be links on Orion Corporation's wall to pages maintained by external parties. Orion Corporation is not responsible for the content of pages maintained or published by external parties. Thank you for being part of building Orion Pharma's page and for following our common rules. The page administrator is Orion Corporation.

27/05/2026

“Conflict resolution skills are not just for experts or diplomats; they belong to all of us.” 🌿

At Orion Pharma, every breakthrough starts with people. It is the expertise, curiosity and dedication of Orionees that turn innovation into real impact for patients.

By building well-being through a culture of collaboration, we help strengthen the resilient healthcare systems that stable societies depend on.

is part of our collaboration with CMI — Martti Ahtisaari Peace Foundation. Learn more at prescriptionsforpeace.fi.

19/05/2026

How much do you really know about asthma? A lot of common beliefs about it don't quite hold up, and clearing them up matters:

🫁 Asthma is chronic inflammation of the airways, ranging from mild to severe.​
🚴 Staying active is part of good asthma care.​
🩺 Asthma is best managed with a doctor's support.

13/05/2026

You have the right to live your life to the fullest – today and tomorrow.​

That’s why we develop innovative respiratory treatments and delivery solutions that help people manage respiratory conditions, improve lung health, and relieve allergy symptoms.​

In 2025, 1.5 million people worldwide used our inhalers to manage the symptoms of asthma or COPD. 🫁

Orion Pharma and CMI – Martti Ahtisaari Peace Foundation work in different fields, yet we both want to contribute to som...
11/05/2026

Orion Pharma and CMI – Martti Ahtisaari Peace Foundation work in different fields, yet we both want to contribute to something societies depend on: stability.

For CMI, this means dialogue before conflicts escalate. For Orion Pharma, it means helping ensure patients can access their medicines in ordinary times and in crises alike.

Read more about our collaboration, link in the comments 👇

08/05/2026

Living with asthma should not mean planning your day around your breathing. 🫁​

Today, asthma care is increasingly focused on long-term control. In everyday terms, that can mean fewer disruptions and more predictability at home, at work, during sleep, and when you move.​

Three things often make a difference:​

🩺 Making sure the diagnosis is confirmed with appropriate tests​
🔄 Having regular follow-ups, not only visits triggered by a flare-up​
📋 Using a clear action plan that helps you know what to do when symptoms change, and when to seek medical advice

05/05/2026

Breathlessness, coughing, or occasional wheezing are easy to brush off – but they may be telling you something important. 🫁

Asthma is often recognised later than it should be, which can make management harder down the line.

Professor Matteo Bonini explains what early diagnosis means in practice and why long-term control should be the goal – link in the comments. 👇

29/04/2026

"In conflicts, there is always hope: because what people have started, they can also end." 🌿

Hope takes many forms. At Orion Pharma, our aim is to bring hope by investing in innovative treatments that address unmet medical needs.

Our pharmaceutical research and development focuses on oncology and pain, driven by one clear goal: to improve the quality of life for patients around the world.

is part of our collaboration with CMI — Martti Ahtisaari Peace Foundation. Learn more 👉 https://cmi.fi/about-us/prescriptions-for-peace/

28/04/2026

Patients don't often describe their lives in clinical language. They describe what illness means in practice:

😴 Can I sleep through the night?
🚶 Can I leave the house without fear?
🗓️ Can I make plans without expecting the next symptom?

These descriptions can reveal things that clinical metrics alone do not fully show – and this is one of the reasons patient journey mapping is so valuable to us at Orion Pharma.

By listening closely to patients’ own words, it becomes possible to build a fuller picture of life with a condition – and to create support that better reflects real-life needs. 💙

24/04/2026

Building well-being takes more than data and numbers – it takes listening to lived experience. 💙

At Orion Pharma, patient journey mapping helps us bring together insights from conversations with patients, caregivers, and healthcare professionals so we can better understand what everyday life really looks like.

This wider understanding can guide:
🔬 how clinical trials are designed
🤝 how support tools are developed, and
💬 how communication speaks to patients' everyday realities.

23/04/2026

Orion Group Interim Financial Report 1–3/2026 has been published.

The year has started strong with growth in both net sales and operating profit.

Learn more on our website ➡️ www.orionpharma.com

Osoite

Orionintie 1 A
Espoo
02200

Puhelin

+358104261

Nettisivu

https://www.orionpharma.com/contact-us/product-related-questions-and-feedback/

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita Orion Pharma :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Ota Yhteyttä Yritys

Lähetä viesti Orion Pharma :lle:

Jaa